Darktrace PLC
LSE:DARK

Watchlist Manager
Darktrace PLC Logo
Darktrace PLC
LSE:DARK
Watchlist
Price: 576.8 GBX Market Closed
Market Cap: £4B

Darktrace PLC
Investor Relations

Darktrace PLC emerged onto the cyber-security scene like a beacon of innovation in 2013, founded in the tech-hub city of Cambridge, UK. The brainchild of artificial intelligence experts and former operatives from British intelligence agencies, Darktrace has been at the forefront of transforming how businesses perceive and combat cyber threats. The company's core offering revolves around its proprietary technology known as the Enterprise Immune System, which applies advanced machine learning and AI algorithms to detect and respond autonomously to cyber threats in real-time. Inspired by the human body's ability to identify and respond to pathogens, Darktrace's system self-learns the 'pattern of life' of every network, device, and user within an organization, thereby distinguishing between benign and potentially harmful activities without relying on known signatures or threat patterns.

The financial model that powers Darktrace's growth is rooted in its subscription-based service offerings, which provide recurring revenue streams as companies continuously rely on its AI systems for real-time threat detection. This model not only ensures a steady cash flow but also allows Darktrace to scale efficiently as its customer base grows across various industries, including finance, healthcare, and utilities. By offering a blend of cutting-edge technology with vital real-time updates, the company makes cybersecurity a manageable and proactive process for its clients. As the digital landscape becomes more complex and threats more sophisticated, Darktrace positions itself not merely as a solution provider but as a strategic partner in safeguarding the digital frontier.

Show more
Loading
DARK
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2024
Call Date
Mar 7, 2024
Q2 2024 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Other Earnings Calls
2024
2022

Management

Ms. Catherine A. Graham
CFO & Executive Director
No Bio Available
Ms. Poppy Clare Veronica Gustafsson O.B.E.
Executive Director
No Bio Available
Ms. Jill Popelka
CEO, COO & Director
No Bio Available
Mr. Jack Stockdale O.B.E.
Co-Founder & CTO
No Bio Available
Mr. Luk Janssens
Head of Investor Relations
No Bio Available
Mr. James Alan Sporle
General Counsel & Company Secretary
No Bio Available
Mr. John Allen
Vice President of Cyber Risk & Compliance
No Bio Available
Mr. Chris Kozup
Chief Marketing Officer
No Bio Available
Mr. David Smith
Chief People Officer
No Bio Available
Ms. Nicole Eagan
Chief Strategy Officer & AI Officer
No Bio Available

Contacts

Address
CAMBRIDGE
Maurice Wilkes Building, St John's Innovation Park, Cowley Road
Contacts